Effect of hyperthermia on spermidine/spermine N1-acetyltransferase activity in Ehrlich ascites cells. 1987

I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
Department of Biochemistry, Osaka City University Medical School, Japan.

When Ehrlich ascites tumor cells were incubated at 42 degrees C, the activity of spermidine/spermine N1-acetyltransferase, a rate-limiting enzyme of polyamine biodegradation, decreased to 20% of the control level within 1 hr. Protein synthesis, judged from the incorporation of [3H]leucine into the acid-insoluble fraction, was less affected by heat exposure. The decrease in the enzyme activity caused by heat treatment could be reversed by switching the incubation temperature back to 37 degrees C. The reversion of enzyme activity was suppressed by cycloheximide but not by actinomycin D.

UI MeSH Term Description Entries
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D000123 Acetyltransferases Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1. Acetyltransferase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
January 1998, Methods in molecular biology (Clifton, N.J.),
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
January 2008, Cell biology international,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
November 1994, Biochemical Society transactions,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
June 2016, Monoclonal antibodies in immunodiagnosis and immunotherapy,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
January 1988, Advances in experimental medicine and biology,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
April 2012, Molecular and cellular biology,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
March 1989, Acta physiologica Scandinavica,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
February 1997, Biochemical and biophysical research communications,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
November 2013, The international journal of neuropsychopharmacology,
I Matsui-Yuasa, and S Otani, and S Morisawa, and K Kageyama, and Y Onoyama
February 1995, Biochemistry,
Copied contents to your clipboard!